Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Zi Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3953-0493; OpenAlex author ID A5100338337. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2026: 4 papers

Papers 4

  1. Diagnostic performance of multislice spiral computed tomography in differentiating pancreatic acinar cell carcinoma from pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-026-05617-8↗
  2. Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-γ/IFN-β/TGF-β cocktail mRNA-LNP. Co-author DOI 10.1038/s41423-026-01390-2↗
  3. AI-driven tumor heterogeneity quantification and survival prediction in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41746-026-02979-7↗
  4. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography Last author DOI 10.21203/rs.3.rs-10196272/v1↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuai Ren · 2 shared papers, 2026 · strength 0.69
  2. Wenli Qiu · 1 shared paper, 2026 · strength 0.36
  3. Yingying Cao · 1 shared paper, 2026 · strength 0.33
  4. Fan Xia · 1 shared paper, 2026 · strength 0.33
  5. Jie Yu · 1 shared paper, 2026 · strength 0.33
  6. Qi Lan · 1 shared paper, 2026 · strength 0.33
  7. Bo Huang · 1 shared paper, 2026 · strength 0.23
  8. Heng Zhang · 1 shared paper, 2026 · strength 0.23
  9. Yabo Zhou · 1 shared paper, 2026 · strength 0.23
  10. Jiadi Lv · 1 shared paper, 2026 · strength 0.23
  11. Haitao Zhang · 1 shared paper, 2026 · strength 0.22
  12. Lizhi Shao · 1 shared paper, 2026 · strength 0.22
  13. Junliang Lu · 1 shared paper, 2026 · strength 0.22
  14. Zhiyong Liang · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.